When: Close above $166.06 on >2.5M shares AND MACD histogram positive

Then: Full position addition

When: Price in $164-166 range at decision time

Then: No new capital deployment; hold neutral

HOLD on BNY Mellon; buy the dip to $162-$163 on FOMC confirmation; scale to 50% position now with $156 stop; full deployment only after FOMC clears and 50 SMA support confirms.

• MACD bearish cross at 99.4% of 52-week high represents authentic momentum warning, not minor signal—the cross has preceded every material correction in stock history; stop loss at $132.11 (200 SMA) is the honest worst-case framing
• 52-week high historical pattern shows ~50% of 99% of 52-week high marks preceded multi-month consolidation or pullback, not continuation; buying at 99.4% of 52-week high after 60% annual run is 'full price' entry
• FOMC meeting is contested with 90% implied probability of dissent; 15 basis point surprise rate move combined with BNY's 1.05 beta and $174.9 billion investment portfolio creates 4-7% single-day move risk; AUM-linked fee base links stock to rate complex
• Iran conflict tail risk is unpriced—US sanctions on 27 Iranian airlines and escalating regional attacks create correlation regime breakdown in bank stocks; hawkish Fed plus geopolitical shock = 5-10% drawdown in defensive financials within a week
• BNY at 15.9x forward earnings and 2.77x P/B is rich vs. 10-year average of 1.8-2.2x book; 14.1% ROE is fine but not exceptional for a custody bank; PEG of 1.25 at 14% ROE in late-cycle rate environment is fair, not cheap
• 50% sizing with defined $156 stop is textbook institutional event-driven positioning; full deployment at $164.84 with $9/share risk and $110 billion market cap exposes portfolio to $90,000-$100,000 loss on $1M position if hawkish FOMC + Iran triggers gap to $148-$150

→ vs aggressive: MACD -0.09 signal dismissed as too small is exactly how professionals get run over; depth of histogram tells nothing about post-cross trajectory; the cross occurring at 99.4% of 52-week high is the material fact

→ vs aggressive: '52-week high is a launchpad' is empirically backwards; roughly half the time 99% of 52-week high marks preceded consolidation or pullback; the aggressive analyst is cherry-picking winners and ignoring the losers (selection bias)

→ vs aggressive: FOMC 55/46 split framing is wrong; confuses central tendency with tail risk; 90% implied dissent probability makes this a contested meeting where forward guidance, dot plot, and press conference can move rates 10-15 basis points in 48 hours

→ vs aggressive: Iran geopolitical tail risk completely omitted from analysis; Barron's warning about mispriced risk premium on Iran conflict; correlation regime in bank stocks breaks down under hawkish Fed + geopolitical escalation

→ vs aggressive: 15.9x forward P/E and 2.77x P/B is not undervalued; PEG of 1.25 at 14% ROE in late-cycle rate environment is fair, not cheap; year-end $175-$180 target assumes multiple expansion that breaks if Fed surprises hawkish

→ vs aggressive: 'Half-pregnant doesn't work in momentum names' is rhetoric not analysis; 50% sizing with $156 stop is textbook institutional approach to event-driven positioning; aggressive full deployment risks taking trader out of the game at exactly the wrong moment

Tactical starter position (30-40% allocation) with conditional scaling; tight structural stop at $157.14; explicit FOMC-conditional add criteria; portfolio cap of 3-5%

• Starter position of 30-40% of target allocation at current levels acknowledges intact fundamental thesis while preserving dry powder
• Tight stop at 50 SMA ($157.14) — daily close below breaks medium-term uptrend and triggers exit; ATR-based stop at $158.34 (entry $164 minus 2xATR of $5.66)
• Add criteria: +30% on breakout above $166.06 with volume, OR +30% on pullback holding $162 with bullish reversal confirmation
• Scale to full position only after FOMC clears and technical structure confirms — dovish FOMC allows scaling to 75% within 1-2 days; hawkish FOMC with hold at 50 SMA is the dip-buy entry
• Position cap of 3-5% of total portfolio given event risk concentration around contested FOMC and geopolitical tail risk
• Fundamental supports are real: revenue accelerating, net income +34% YoY, $62T custody moat, 4.7% capital return yield, low beta
• Event risk window is genuinely dangerous: 99.4% of 52-week high with fresh bearish MACD cross ahead of contested FOMC with hawkish skew

→ vs conservative: $132.11 stop at 200 SMA means 19.8% drawdown acceptance — not capital preservation, catastrophic loss acceptance. True risk management stop is at 50 SMA or Bollinger lower band ($157-158), representing 4-5% risk. The $132.11 stop is intellectually dishonest as a practical risk parameter.

→ vs conservative: 7% upside vs 20% downside framing depends on $132 stop being realistic exit. With realistic tactical stop at $157, asymmetry is closer to 5% downside vs 7% upside to $166, then potential leg to $175-180 — roughly balanced, not asymmetric.

→ vs conservative: Dip-buying thesis at $162-163 risks missing the move if stock consolidates and breaks out above $166 on FOMC dovishness without revisiting entry level. High-quality compounders in re-rating regimes often don't give the dip you want.

→ vs aggressive: Iran tail risk completely ignored — macro report explicitly flagged it as mispriced. FOMC hawkish surprise combined with geopolitical escalation could produce $148-150 (10% gap down on full deployment) regardless of fundamentals. Full deployment at 99.4% of 52-week high before contested policy meeting is not professional risk management.

→ vs aggressive: NII tailwind and AUM headwind work on different timescales — hike pressures AUM marks immediately through discount rate mechanics while NII benefit accrues over quarters. In immediate post-FOMC window, BNY is more exposed to negative read than positive.

→ vs aggressive: 'Half-pregnant' framing is rhetorical nonsense — half-scaling with defined add criteria is structure, not weakness. Full-deployment has no edge preservation if wrong; scaled approach has defined path to full conviction if thesis confirms.